Gene · 9775
Papers1,749
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
401 to 420 of 1,749
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Targeted Pyroptosis Is a Potential Therapeutic Strategy for Cancer. | J Oncol | 2022 | 36467499 | PubTator, text mining | PubMed |
| The roles of lncRNA functions and regulatory mechanisms in the diagnosis and treatment of hepatocellular carcinoma. | Front Cell Dev Biol | 2022 | 36467404 | PubTator, text mining | PubMed |
| Circular RNA hsa_circ_0007990 as a blood biomarker for unruptured intracranial aneurysm with aneurysm wall enhancement. | Front Immunol | 2022 | 36466848 | PubTator, text mining | PubMed |
| circRNAs and their relationship with breast cancer: a review. | World J Surg Oncol | 2022 | 36443878 | PubTator, text mining | PubMed |
| EIF4A3-induced circBRWD3 promotes tumorigenesis of breast cancer through miR-142-3p_miR-142-5p/RAC1/PAK1 signaling. | BMC Cancer | 2022 | 36443711 | PubTator, text mining | PubMed |
| Non-Coding RNAs in Regulating Plaque Progression and Remodeling of Extracellular Matrix in Atherosclerosis. | Int J Mol Sci | 2022 | 36430208 | PubTator, text mining | PubMed |
| N6-Methyladenosine Modification of CIRCKRT17 Initiated by METTL3 Promotes Osimertinib Resistance of Lung Adenocarcinoma by EIF4A3 to Enhance YAP1 Stability. | Cancers (Basel) | 2022 | 36428672 | PubTator, text mining | PubMed |
| Unveiling Human Proteome Signatures of Heart Failure with Preserved Ejection Fraction. | Biomedicines | 2022 | 36428511 | PubTator, text mining | PubMed |
| Spliceosomal profiling identifies EIF4A3 as a novel oncogene in hepatocellular carcinoma acting through the modulation of FGFR4 splicing. | Clin Transl Med | 2022 | 36419260 | PubTator, text mining | PubMed |
| An RNAi screen of RNA helicases identifies eIF4A3 as a regulator of embryonic stem cell identity. | Nucleic Acids Res | 2022 | 36416264 | PubTator, text mining | PubMed |
| N 6-methyladenosine RNA methylation: From regulatory mechanisms to potential clinical applications. | Front Cell Dev Biol | 2022 | 36407103 | PubTator, text mining | PubMed |
| Hypoxia-induced circRNF13 promotes the progression and glycolysis of pancreatic cancer. | Exp Mol Med | 2022 | 36369467 | PubTator, text mining | PubMed |
| Translational Regulation by eIFs and RNA Modifications in Cancer. | Genes (Basel) | 2022 | 36360287 | PubTator, text mining | PubMed |
| Identification and validation of novel biomarker TRIM8 related to cervical cancer. | Front Oncol | 2022 | 36353542 | PubTator, text mining | PubMed |
| Whole blood circular RNA hsa_circ_0002171 serves as a potential diagnostic biomarker for human adenovirus pneumonia in children. | Braz J Med Biol Res | 2022 | 36350973 | PubTator, text mining | PubMed |
| eIF3j inhibits translation of a subset of circular RNAs in eukaryotic cells. | Nucleic Acids Res | 2022 | 36330957 | PubTator, text mining | PubMed |
| The kinesin motor KIF1C is a putative transporter of the exon junction complex in neuronal cells. | RNA | 2022 | 36316088 | PubTator, text mining | PubMed |
| eIF4A3 Promotes RNA Viruses' Replication by Inhibiting Innate Immune Responses. | J Virol | 2022 | 36314820 | PubTator, text mining | PubMed |
| Systematic analysis of circRNA biomarkers for diagnosis, prognosis and therapy in colorectal cancer. | Front Genet | 2022 | 36313458 | PubTator, text mining | PubMed |
Prognostic value of antitumor drug targets prediction using integrated bioinformatic analysis for immunogenic cell death-related lncRNA model based on stomach adenocarcinoma characteristics and tumor immune microenvironment. | Front Pharmacol | 2022 | 36313374 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/9775/papers?page=21